Free Essay

Generic Prescription Drug Cost Hike

In:

Submitted By kameronh2001
Words 2194
Pages 9
Throughout the past year of presidential campaigning, one of the top issues for both candidates has been that of whether or not there should be a prescription-drug benefit added to Medicare. Both George W. Bush and Al Gore have proposed a plan to expand Medicare to include full prescription-drug coverage for senior citizens receiving Medicare, at the expense of taxpayers. It is obvious why this issue has been such a priority for both candidates. Senior citizens vote at a much higher rate than other age groups. Both candidates know the importance of these senior citizen votes and believe that the proposal of adding a prescription-drug benefit is something that will appeal to a vast number of senior citizens. Both candidates have portrayed the issue as being very critical and as a serious problem that needs to be addressed.

The question, however, is whether or not such drug coverage is a worthwhile project to undertake. Is the problem indeed serious enough to call for the type of reform that the candidates are proposing? Medicare is already a very costly program to keep up, and adding prescription-drug coverage would increase these costs even more. In order to fund this project, there will need to be a tax hike. Should taxpayers subsidize this prescription-drug benefit? Is there a good reason why this redistribution should take place? What are the benefits and costs of this proposal? These and other questions will be addressed in this paper as we examine the following topics: the need for senior citizens to have prescription-drug coverage, the political rhetoric involved with this issue, the projected shortfall in the budget of the Medicare program, and who really would benefit if a prescription-drug benefit was added to Medicare.

Need for Prescription-Drug Coverage

Many people argue that the lack of a prescription-drug benefit is the major shortcoming of the Medicare program. But are Medicare recipients really in need of such a benefit? According to a study done by the AARP Public Policy Institute, about 25.6 million, or 65 percent, of noninstitutionalized Medicare beneficiaries already receive some type of prescription-drug coverage, whether it is through employer-sponsored health plans or individually purchased private health policies. This leaves about 13.5 million Medicare beneficiaries who are without prescription-drug coverage. These 13.5 million Medicare recipients are supposedly the ones that the presidential candidates are attempting to help by proposing this addition to Medicare. However, it is interesting to note that even those who do have prescription-drug coverage from some other source still incur out-of-pocket costs for prescription drugs, although they are less than what is paid by those with absolutely no drug coverage. The average out-of-pocket prescription drug spending of the Medicare recipients with coverage is $320 per year. For Medicare beneficiaries without any drug coverage, the average out-of-pocket spending for prescription drugs was $590 per year. Of course, this figure is the average cost paid by those without insurance. The proposed addition to Medicare is aimed at protecting the relatively few senior citizens who have drug bills in the thousands of dollars annually and who have no relief from these costs. Why don’t these people find some sort of prescription-drug coverage? Of the 13.5 million Medicare beneficiaries without prescription-drug coverage, many of them choose not to be covered because they do not spend enough of drugs to make it worth their money. But some of them are not covered because of some barriers to obtaining drug coverage.

Medicare beneficiaries with employer-sponsored prescription-drug coverage are the largest group of beneficiaries with drug coverage. For those who do not have an employer-sponsored health plan, privately purchased policies are available, such as Medigap. This may be the only option for a lot of the Medicare recipients who do not have any drug coverage. But such policies are not feasible for many of these people with no coverage because of high premiums. High deductibles, high cost-sharing, and benefit caps are other aspects of Medigap that make it difficult or irrational for many people to purchase.

Another option for non-covered seniors on Medicare is to get prescription-drug coverage through their state Medicaid programs. This option, however, is not always available because their income may be too high, or their assest are not sufficiently low to qualify for Medicaid.

These barriers to finding available and affordable prescription-drug coverage have fueled the argument for adding a prescription-drug benefit to Medicare.

Political Rhetoric

Throughout the debate over this issue, both candidates have portrayed our nation’s senior citizens as victims of out-of-control drug prices, unable to pay the backbreaking prescription prices that they must pay in order to be healthy. However, as mentioned earlier, two-thirds of all senior citizens will pay less than $500 in out-of-pocket drug costs per year, while only 7% will pay more than $2000. And not all of those that fall within the 7% are necessarily those who do not have any drug coverage. In the same research cited above by the AARP Public Policy Institute, it was discovered that those with drug coverage from individually purchased policies such as Medigap have some of the highest average annual out-of-pocket costs at $570 per year. This is just less than the average for those with no coverage at all. Simply having coverage doesn’t necessarily protect seniors from huge costs that they are unable to bear.

The real issue then becomes whether or not a substantial number of senior citizens actually face serious financial difficulties because of prescription-drug costs. A USA Today study of this question found that only a small minority of senior citizens is actually in such a situation. Of the one-third of seniors without prescription-drug coverage, many of them are poor enough to qualify for Medicaid coverage, which could relieve them of some of their out-of-pocket drug costs. Those who are not poor enough to qualify for Medicaid are usually affluent enough to pay their own bills. They may have higher average out-of-pocket costs to fill their prescriptions, but at the same time they are able to pay it and don’t mind doing so. In fact, many choose to go this route rather than paying premiums on private supplemental coverage.

The numbers and evidence from the prescription-drug coverage analysis, along with the information about the proposed Medicare reform, suggest that the presidential candidates are proposing a solution that sounds good to all senior citizens, since they are proposing that all seniors would be covered under the plan, but that in reality will still leave the same individuals with the highest drug costs with huge prescription-drug bills to pay, due to the limits of the coverage.

Why would the presidential candidates be so adamant about a redistribution of taxpayer dollars that seems to be unnecessary? I’m sure it has to do with the fact that voter turnout increases with age. During the last presidential election in 1996, nearly three-fourths of people 70 years old and up voted, compared to only 35% of registered voters under 25. Senior citizens were expected to be the key “swing voters” in this year’s presidential election, so it is no wonder that both candidates have been in favor of adding a prescription-drug benefit to Medicare at the expense of taxpayers.

But if senior citizens are really not in need of this new prescription-drug benefit, and if other drug coverage is available to most of them, and in fact already owned by over two-thirds of them, who will really benefit from giving this benefit to all Medicare recipients? The answer to this question will be discussed later. But we first need to address the issue of Medicare’s projected budget shortfall.

Projected Shortfall in Medicare Budget

Perhaps the biggest problem with the proposal of a new prescription-drug benefit for Medicare is the fact that Medicare is currently in a very thorny financial situation. According to official government estimates, Medicare will begin to run out of money starting at about the year 2010. That will be when the “baby boomers” begin to qualify for Medicare benefits. That is why the currently proposed addition of a prescription-drug benefit to Medicare seems so irrational. Looking toward the future, we will either need to raise taxes or cut benefits simply to keep Medicare from going broke. The question that the presidential candidates should be addressing is how the government plans to pay for Medicare as it currently exists, not whether or not we should add a costly new prescription-drug benefit. Even if taxes are raised and they find a way to pay for the prescription-drug benefit, we will still be left facing a grim future for the Medicare budget.

In order to fund the proposed prescription-drug benefit to Medicare, it would become necessary to either increase taxes and redistribute this tax revenue into the Medicare budget in order to cover increased costs, or to cut back on some of the current Medicare budget. The second option seems impractical since nearly everyone agrees that it is definitely not fewer benefits, but a larger budget, that Medicare is in need of. A USA Today poll showed that voters would much rather pay higher taxes than cut benefits in order to correct for the projected deficit in the Medicare budget. Ninety-one percent of the people surveyed said that the government should do something now to prepare for this future shortfall. Fifty-six percent were in favor of raising taxes to do so, and only 12% were in favor of cutting benefits. Thus both presidential candidates have proposed a tax increase to cover the expense of the new drug benefit plan, as this seems to be the desirable solution given the options available.

By proposing a tax increase to fund the addition of a prescription-drug benefit to Medicare, the presidential candidates are ignoring the more pressing budgetary issues faced by the Medicare program and creating something that will appeal to senior voters, but that is for the most part unnecessary.

Who Would Really Benefit?

In analyzing the proposal for a prescription-drug benefit to the Medicare program, we need to be sure and point out who the true beneficiaries of such a new program would be. As was mentioned earlier, two-thirds of those over age 65 already have prescription-drug coverage, and one-third does not. Of the one-third of seniors who don’t already have prescription-drug coverage, they either have access to Medicaid or else they are wealthy enough to pay their own bills. Thus, only a small portion of seniors (the ones who are rich enough to pay for their drugs out of their own pockets) would benefit from the addition of prescription-drug coverage to Medicare because they would have some of their drug costs covered when before they were not concerned about it, they simply paid for everything themselves and did not mind doing so. This is an inefficient transfer because the rich are simply becoming richer.

Of the two-thirds who already have some type of prescription-drug coverage, a new prescription-drug benefit added to Medicare would not benefit them in any significant way, since most of them already have employer-sponsored supplemental health insurance which includes prescription-drug coverage. They would most likely continue to receive this coverage, and Medicare would simply replace their previous prescription-drug coverage, saving their previous insurance company considerable costs previously paid out for prescription drugs. Thus, we can see that the largest beneficiary of this whole prescription-drug benefit for Medicare would be the private insurance and employer-sponsored insurance companies who have been providing prescription-drug coverage to seniors. These companies are mostly major corporations and would save about $50 billion over five years by having Medicare pay for their customer’s prescription drug expenses for them. Basically, the government would be letting employer-sponsored and private Medicare supplemental insurance companies off the hook.

A transfer from taxpayers to wealthy senior citizens and to large insurance companies seems very inefficient, inequitable, and undesirable, but this is basically what the presidential candidates are proposing with the addition of a prescription-drug benefit to Medicare.

Conclusion

In summary, there are several reasons why the expansion of Medicare to include a prescription-drug benefit would be inefficient and unnecessary. Although it may sound appealing to senior citizens, in reality only a very small portion of them need or even want such a benefit. Generally speaking, most senior citizens already have prescription-drug coverage or else have enough money to pay for their prescription drugs themselves. The presidential candidates should have been addressing the more important issue of how we will pay for Medicare as it exists now. Medicare needs to be reformed to prepare for the inevitability of future bankruptcy and collapse before we should look at adding new benefits.

How to Cite this Page

MLA Citation: "Expanding Medicare to Include Prescription Drug Coverage." 123HelpMe.com. 20 Nov 2015

Similar Documents

Premium Essay

Persuasive Essay On Free Prescriptions

...Who would have thought that drug companies could put such a high price on living only to line their own pockets? Americans pay, substantially, more for prescription medications than the rest of the world. These drugs do no good to the people who are prescribed them if they aren’t able to afford them. In 2013, per capita spending on prescriptions was $858 compared with an average of $400 in 19 other industrialized countries. That’s more than double the average spending of other high income countries for the same medications. Every year from 2006 to 2015 the retail prices for highly used brand named drugs increased substantially faster than general inflation. With the prices of drugs increasing at a faster rate than inflation the ability to pay...

Words: 844 - Pages: 4

Premium Essay

The Pros And Cons Of Epipen

...anaphylaxis. Mylan offers the first authorized generic for EpiPen Auto injector at half of the wholesale acquisition cost . But as of 2016 , Mylan's EpiPen became the center of attention for scrutiny . Their prices increased by nearly 500 percent over the past seven years. American consumers are definitely not strangers to increased prices on drugs , but based on a few steep price hikes by the Mylan company and their decision to raise the price on EpiPen it caused an outrage. Mylan was at the center of criticism over rising drug prices. EpiPen is basically used by several parents of young children that suffer from food...

Words: 517 - Pages: 3

Free Essay

Healthcare Policy

...or Obamacare) costs of pharmaceuticals continue to rise. In addition to the spiraling costs of the health care system, pharmaceutical companies continue to benefit from high profit margins while Americans are left paying three times as much for the same medications as other nations across the globe (Picchi 2015). In order for the Obama Administration to achieve their goal of healthcare for every American, legislation must be implemented that allows price negotiation among medical providers, the federal government and the pharmaceutical companies. Despite the persistent claims by many high ranking elected officials, such as former Senate Majority Leader John Boehner, that America has the best health care system in the world, there's insufficient evidence that Americans are getting higher-quality medical treatment or enjoying healthier lives than our counterparts abroad (Jacobson 2012). According to the Commonwealth Fund, Healthcare in America costs more than in other industrialized nations and Americans aren't getting the world's best care for their dollars, according to a new study. The United States spent $7,960 per capita on health care in 2009, the most of 13 industrialized nations in the Organization for Economic Cooperation and Development. That's almost three times the amount spent in Japan, which has the lowest expenses of the countries reviewed (Leflar 2013). Americans pay the highest prices for physician visits, hospital treatments and prescription drugs and get expensive...

Words: 2364 - Pages: 10

Premium Essay

Economics

...reached $1,057,000,000 in 2014; based on the past 10 years we can expect the forecast to show a similar increase over the next few years. IMS Health Market Prognosis, May 2015 Of all the changes visible within the pharmaceutical market, there are a few that are truly revolutionizing the market: US healthcare reform, emergence of specialty product markets, price strategy & mergers & acquisitions. The healthcare market has changed under Obama, opening healthcare coverage to more patients & bringing forth treatment & medication to a larger population. The emergence of specialty products pose an entirely new challenge to the market in terms of the doctor’s prescribing habits, healthcare plan coverage & out-of-pocket cost to the patient. This along with other economic pressures brings an entirely new perspective to pharmaceutical manufacturers in terms of pricing strategy & overall price elasticity of demand. Additionally, in attempt to stay ahead in a very competitive market, many pharmaceutical manufacturers are dependent upon large mergers & acquisitions in order to gain market share, increase profits & achieve their financial goals. Understanding the influence of these changes is critical in...

Words: 3963 - Pages: 16

Free Essay

Analysis

...IMS Market Prognosis 2009-2013 EUROPE RUSSIA © 2009 IMS Health Incorporated or its affiliates. All rights reserved. IMS HEALTH 7 Harewood Avenue London NW1 6JB, UK Tel: +44 (0)20 3075 5888, Fax: +44 (0)20 3075 5999 service@imshealth.com http://www.imshealth.com The Information Service contained herein is confidential and provided subject to the IMS Health Information Services Standard Terms and Conditions. This Information Service is provided to the client on a personal basis under a non-exclusive and non-transferable licence for the Client’s own direct benefit and use only, and may not be copied or divulged to any other party. Whilst every possible care has been taken in the preparation of this information, the publishers do not hold themselves responsible for any expressions of opinion or error or omission, or any action resulting therefrom. © 2009 IMS Health Incorporated or its affiliates. All rights reserved. Published: June 2009 IMS Market Prognosis Europe 2009-2013 Russia 2009 Table of Contents MARKET SYNOPSIS ....................................................................................................6 FORECAST SUMMARY .................................................................................................8 MARKET FORECAST ...................................................................................................................................... 8 THERAPEUTIC CLASS FORECASTS ........................................

Words: 40871 - Pages: 164

Premium Essay

Internship Report on Janata Bank Ltd

...channels to make their product available to the customers and at a comfortable place. The ACME Laboratories Ltd. has also endeared to strength its network in international marketing operation to export products abroad. The company provides some motivational tools to the internal sales team. The company provides fringe benefit to these people. It is the most successive tool for the company. From the study we find that the ACME Laboratories Ltd. is a socially responsible company, and practice ethical values. From the study it has appeared that the ACME Laboratories Ltd. is facing some minor marketing problems. So to overcome these problems the ACME Laboratories Ltd. will be extending their business rapidly. Key Words: Pharmaceutical, Industry, Drug, Marketing, Acme. Introduction Pharmaceutical Industry has grown in Bangladesh in the last two decades at a considerable rate. The sector consistently creates job opportunities for highly qualified people. Many established...

Words: 5228 - Pages: 21

Premium Essay

Obamacare

...the Affordable Care Act. The law puts in place comprehensive health insurance reforms that will roll out over four years and beyond. Use the links below to learn about what’s changing and when: OVERVIEW OF THE HEALTH CARE LAW 2010: A new Patient's Bill of Rights goes into effect, protecting consumers from the worst abuses of the insurance industry. Cost-free preventive services begin for many Americans. See More 2010 Changes. 2011: People with Medicare can get key preventive services for free, and also receive a 50% discount on brand-name drugs in the Medicare “donut hole.” See More 2011 Changes. 2012: Accountable Care Organizations and other programs help doctors and health care providers work together to deliver better care. See More 2012 Changes. 2013: Open enrollment in the Health Insurance Marketplace begins on October 1st. See More 2013 Changes. 2014: All Americans will have access to affordable health insurance options. The Marketplace allows individuals and small businesses to compare health plans on a level playing field. Middle and low-income families will get tax credits that cover a significant portion of the cost of coverage. And the Medicaid program will be expanded to cover more low-income Americans. All together, these reforms mean that millions of people who were previously uninsured will gain coverage, thanks to the Affordable Care Act. See More 2014 Changes. 2010  NEW CONSUMER PROTECTIONS • Putting Information for Consumers Online. The law...

Words: 3433 - Pages: 14

Premium Essay

Valuation of Ambee Pharmaceuticals Limited, Bangladesh

...601 Course - TERM PAPER Financial Statement Analysis & Valuation AMBEE PharmaceuticalsLtd. ENTERPRISE VALUATION & ANALYSIS OF BUSINESS AMBEE Pharmaceuticals Limited T able of Contents Chapter - 01 Chapter - 02 Chapter - 03 Chapter - 04 Chapter - 05 About the Company Strategy Analysis Valuation Conclusion Annexure ………………………… ………………………… ………………………… ………………………… 01 03 11 21 A M B E E P H A R M A : V A L U A T I O N 1 Chapter About the Company The company’s operation & historical performances were moderate and they were not leading the market from their inception A MBEE PHARMACEUTICALS LTD., was established in 1976 in Bangladesh. This public limited company was registered under the companies Act, 1913 and was incorporated in Bangladesh on 4th February 1976. Ambee has a joint venture with a famous multinational company Medimpex of Hungary. Ambee started its operation with modest 17 joint ventured products and is now running in full swing with 76 products. They have Tablets, Capsules, Liquids, and Gel in tubes and Injectables. Its operational area covers all over Bangladesh with a large number of field forces who strive hard to establish the demand of products of the company in every corner of the country. The company maintains four outside Depots located at Khulna, Bogra, Chittagong and Sylhet besides its National Distribution Cell in Dhaka. When Ambee Pharmaceutical Ltd.(APL) was launched back in Feb’ 1976, Ambee had only 30 field forces...

Words: 5420 - Pages: 22

Premium Essay

Price War

...How to Fight a Price War By Akshay R. Rao, Mark E. Bergen and Scott Davis IN THE BATTLE TO CAPTURE THE CUSTOMER companies use a wide range of tactics to ward off competitors. Increasingly, price is the weapon of choice – and frequently the skirmishing degenerates into a price war. Creating low price appeal is often the goal, but the result of one retaliatory price slashing after another is often a precipitous decline in industry profits. Look at the airline price wars of 1992. When American Airlines, Northwest Airlines, and other U.S. carriers went toe-to-toe in matching and exceeding one another’s reduced fares, the result was record volumes of air travel-and record losses. Some estimates suggest that the overall losses suffered by the industry that year exceed the combined profits for the entire industry from its inception. Price wars can create economically devastating and psychologically debilitating situations that take an extraordinary toll on an individual, a company, and industry profitability. No matter who wins, the combatants all seem to end up worse off than before they joined the battle. And yet, price wars are becoming increasingly common and uncommonly fierce. Consider the following two examples: • In July 1999, Sprint announced a nighttime long-distance rate of 5 cents per minute. In August 1999, MCI matched Sprint’s off-peak rate. Later that month, AT & T acknowledged that revenue from its consumer long-distance business was falling,...

Words: 6913 - Pages: 28

Premium Essay

How to Fight a Price War

...If you find yourself facing a price war, you'll need to understand how it started in order to respond effectively. Often the best counterattack does not. involve a retaliatory price How by Akshay R. Rao, Mark E. Bergen, and War ^ 1 I 1^ f Scott Davis N THE BATTLE TO CAPTURE THE CUSTOMER, companies use a wide range of tactics to ward off competitors. Increasingly, price is the weapon of choice - and frequently the skirmishing degenerates into a price war. Creating low-price appeal is often the goal, hut the result of one retaliatory price slashing after another is often a precipitous decline in industry profits. Look at the airline price wars of r992. When American Airlines, Northwest Airlines, and other U.S. carriers went toe-to-toe in matching and exceeding one another's reduced fares, the result was record volumes of air travel-and record losses. Some estimates suggest that the overall losses suffered hy the industry that year exceed the combined profits for the entire industry from its inception. Price wars can create economically devastating and psychologically dehilitating situations that take an extraordinary toll on an individual, a com- HARVARD BUSINESS REVIEW March-April 2000 107 How to Fight a Price War pany, and industry profitability. No matter who wins, the comhatants all seem to end up worse off than before they joined the battle. And yet, price wars are becoming increasingly common and uncommonly ...

Words: 5496 - Pages: 22

Premium Essay

Manager

...Learning with Cases INTRODUCTION The case study method of teaching used in management education is quite different from most of the methods of teaching used at the school and undergraduate course levels. Unlike traditional lecture-based teaching where student participation in the classroom is minimal, the case method is an active learning method, which requires participation and involvement from the student in the classroom. For students who have been exposed only to the traditional teaching methods, this calls for a major change in their approach to learning. This introduction is intended to provide students with some basic information about the case method, and guidelines about what they must do to gain the maximum benefit from the method. We begin by taking a brief look at what case studies are, and how they are used in the classroom. Then we discuss what the student needs to do to prepare for a class, and what she can expect during the case discussion. We also explain how student performance is evaluated in a case study based course. Finally, we describe the benefits a student of management can expect to gain through the use of the case method. WHAT IS A CASE STUDY? There is no universally accepted definition for a case study, and the case method means different things to different people. Consequently, all case studies are not structured similarly, and variations abound in terms of style, structure and approach. Case material ranges from small caselets (a few paragraphs...

Words: 239776 - Pages: 960

Premium Essay

Strategy Case Studies

...direction in the form of '10,10,10' goal. However, Korean Air is held up by a slew of challenges. Among which are inefficiencies of - Chaebol system of management, possible clash of its cargo business with its own shipping company, limited focus on the domestic market and growing competition from LCCs. How would Korean Air manage growth as a family-owned conglomerate? The case offers enriching scope for analysing a family business’s turnaround strategies, with all the legacy costs involved. Pedagogical Objectives • To discuss the (operational) dynamics of Korean Chaebols - their influence/ effects on the country’s industrial sector and the economy as a whole • To analyse how family-owned businesses manage the transition phase - from a supplier-driven economy to a demanddriven economy • To identify all the possible reasons for Korean Air ’s turbulent times and assessing whether they are controllable or not • To critically evaluate Korean Air ’s transformation efforts - in terms of growth, productivity and cost cuts, especially the efficacy of '10,10,10' goal in a family-run business • To identify various challenges to Korean Air in...

Words: 71150 - Pages: 285

Free Essay

Newborn Health

...U.N. Commission on Life Saving Commodities for Women and Children: Country Case Studies May 2012 This is a working document. It has been prepared to facilitate the exchange of knowledge and to stimulate discussion. The findings, interpretations, and conclusions expressed in this paper are those of the authors and do not necessarily reflect the policies or views of the United Nations Commission on Life-Saving Commodities for Women and Children or the United Nations. The text has not been edited to official publication standards, and the Commission accepts no responsibility for errors. The designations in this publication do not imply an opinion on legal status of any country or territory, or of its authorities, or the delimitation of frontiers. Contributors and Acknowledgements Sarah Blake,1 Aubrey Cody,1 Anjali Kaur,1 Nejla Liias, 1 Christopher Lindahl,2 Emily Bell,1 Julie Kragh,1 Jessica Mack,1 and Kristin Cox Mehling1 served as researchers and authors of this working paper. The authors would like to thank the following individuals for their contributions to the development and conceptualization of these case studies: Oliver Sabot Hans Hogerzeil Patricia Mechael Catherine Taylor Kanika Bahl Julia White Kabir Ahmed Mark Young Renee van de Weerdt Deborah Armbruster Jennifer Lockwood-Bergeson Michael Mbizvo Clinton Health Access Initiative Groningen University mHealth Alliance PATH Results for Development Institute UN Secretariat UNFPA UNICEF UNICEF USAID USAID WHO ...

Words: 60793 - Pages: 244

Free Essay

Sample Business Plan

...2014 Trends Report Top 10 Global Spa and Wellness Trends Forecast 2014 Trends Report Top 10 Global Spa and Wellness Trends Forecast This is our 11th annual Trends Forecast, and I have never been more excited about the spa and wellness industry. So many of the trends we predicted over the past decade are now coming to fruition…helping businesses thrive and helping people live more healthfully every day. At the same time, we are seeing new, provocative ideas that will have a dramatic impact around the globe. The 2014 trends reflect an industry that is reimagining core elements of spa and wellness and exploring brave, new directions. It is gratifying to see a healthy dose of healthy travel in several of the trends; bold new ideas in mainstays like aromatherapy and hot springs take hold; and the development of new models for classic destination spas. It is also rewarding to watch trends in technology, beauty and fitness shape how we will live (and look)—and even take note of how the industry will help people address dying, illness and major life changes. And finally, there is a trend we forecasted in 2013 that continues to capture our imagination: mindfulness. We feel strongly that it is important to watch how this is evolving, and you’ll see a short synopsis of this “über trend” in the report. Spafinder Wellness 365™’s Trends Forecast reports on what is happening in our industry, but we also strive to present a true forecast of what lies ahead. Some ideas are still on...

Words: 28888 - Pages: 116

Premium Essay

Business

...Parliament of Australia Department of Parliamentary Services Parliamentary Library Information, analysis and advice for the Parliament RESEARCH PAPER www.aph.gov.au/library 26 May 2010, no. 17, 2009–10, ISSN 1834-9854 Budget Review 2010–11 Last year’s Budget was framed amid a sharply deteriorating world economy which was considered the most challenging global economic conditions since the Great Depression. In 2009, the global economy contracted for the first time in the post-war era. In contrast, Australia grew by almost 1.5 per cent supported by monetary and fiscal policy stimulus, a well-functioning banking system, and strong growth in a number of East Asian economies. The third Rudd Government Budget, presented on 11 May 2010, was developed within an improving but still uncertain outlook, with events in Greece and other European Union countries reminding us of the risks to the global economic recovery. Strong economic growth in China and India is expected to continue to flow throughout the region and, despite a slower pace, the US is leading the recovery among our advanced economy major trading partners. Global economic growth is in the early stages of recovery but we should remain cognisant of the precarious economic environment which is continuing to challenge government policy makers around the globe. Once again the Parliamentary Library has produced the annual Budget Review that examines the key features of a selection of crucial measures contained...

Words: 85921 - Pages: 344